.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Harvard Business School
Novartis
Citi
Deloitte
Healthtrust
Medtronic
Moodys
Johnson and Johnson

Generated: November 20, 2017

DrugPatentWatch Database Preview

Naltrexone hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for naltrexone hydrochloride and what is the scope of naltrexone hydrochloride freedom to operate?

Naltrexone hydrochloride
is the generic ingredient in three branded drugs marketed by Accord Hlthcare, Apotex Inc, Barr, Teva Womens, Sandoz, Sun Pharma Global, Mallinckrodt, Elite Labs, and Pfizer Inc, and is included in nine NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for naltrexone hydrochloride. Thirteen suppliers are listed for this compound.

Pharmacology for naltrexone hydrochloride

Drug ClassOpioid Antagonist
Mechanism of ActionOpioid Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer Inc
TROXYCA ER
naltrexone hydrochloride; oxycodone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL207621-005Aug 19, 2016RXNoNo► Subscribe► Subscribe ► Subscribe
Pfizer Inc
TROXYCA ER
naltrexone hydrochloride; oxycodone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL207621-005Aug 19, 2016RXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
NALTREXONE HYDROCHLORIDE
naltrexone hydrochloride
TABLET;ORAL075434-001Mar 8, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
TROXYCA ER
naltrexone hydrochloride; oxycodone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL207621-004Aug 19, 2016RXNoNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
TROXYCA ER
naltrexone hydrochloride; oxycodone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL207621-002Aug 19, 2016RXNoNo► Subscribe► SubscribeY ► Subscribe
Barr
NALTREXONE HYDROCHLORIDE
naltrexone hydrochloride
TABLET;ORAL074918-001May 8, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
TROXYCA ER
naltrexone hydrochloride; oxycodone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL207621-004Aug 19, 2016RXNoNo► Subscribe► Subscribe ► Subscribe
Pfizer Inc
TROXYCA ER
naltrexone hydrochloride; oxycodone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL207621-003Aug 19, 2016RXNoNo► Subscribe► Subscribe ► Subscribe
Pfizer Inc
TROXYCA ER
naltrexone hydrochloride; oxycodone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL207621-002Aug 19, 2016RXNoNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
TROXYCA ER
naltrexone hydrochloride; oxycodone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL207621-006Aug 19, 2016RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Express Scripts
McKesson
Chubb
Daiichi Sankyo
Farmers Insurance
Johnson and Johnson
Accenture
Baxter
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot